BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,320 | +40.5% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $4,499 | +2.7% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,381 | -37.4% | 100 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $7,000 | +40.0% | 100 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $5,000 | -16.7% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $6,000 | -45.5% | 100 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $11,000 | +10.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $10,000 | +11.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | -10.0% | 100 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $10,000 | -9.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $11,000 | +22.2% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,000 | +12.5% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $8,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $8,000 | 0.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $8,000 | +14.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $7,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |